Crossmark

Highly selective inhibition of Bruton’s tyrosine kinase attenuates skin and brain disease in murine lupus

Crossref DOI link: https://doi.org/10.1186/s13075-017-1500-0

Published Online: 2018-01-25

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chalmers, Samantha A.

Wen, Jing

Doerner, Jessica

Stock, Ariel

Cuda, Carla M.

Makinde, Hadijat M.

Perlman, Harris

Bosanac, Todd

Webb, Deborah

Nabozny, Gerald

Fine, Jay S.

Klein, Elliott

Ramanujam, Meera

Putterman, Chaim http://orcid.org/0000-0002-3204-6068
Funding

Funding for this research was provided by:

Boehringer Ingelheim (N/A)
More Information

Article History

Received: 27 June 2017

Accepted: 20 December 2017

First Online: 25 January 2018

Ethics approval

: Animal studies were approved by the institutional animal care committee of the Albert Einstein College of Medicine (Bronx, NY, USA).

: Not applicable.

: Todd Bosanac, Deborah Webb, Gerald Nabozny, Jay Fine, Elliott Klein, and Meera Ramanujam are full-time employees of Boehringer Ingelheim (Ridgefield, CT). The other authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.